253 related articles for article (PubMed ID: 12854284)
1. [Male osteoporosis: current treatments and future options].
Romagnoli E; Paglia F; Dionisi S; De Geronimo S; Pepe J; Di Virgilio R; Minisola S
Clin Ter; 2003; 154(1):49-53. PubMed ID: 12854284
[TBL] [Abstract][Full Text] [Related]
2. The potential of parathyroid hormone as a therapy for osteoporosis.
Rubin MR; Bilezikian JP
Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
De Nijs RN
Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
[TBL] [Abstract][Full Text] [Related]
4. [Anabolic treatment for osteoporosis: PTH treatment].
Kaji H; Sugimoto T
Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
[TBL] [Abstract][Full Text] [Related]
5. Osteoporosis: strategies for prevention and management.
Keen R
Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):109-22. PubMed ID: 17350547
[TBL] [Abstract][Full Text] [Related]
6. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture.
Seeman E; Eisman JA
Med J Aust; 2004 Mar; 180(6):298-303. PubMed ID: 15012571
[TBL] [Abstract][Full Text] [Related]
7. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid-induced osteoporosis.
Berris KK; Repp AL; Kleerekoper M
Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
10. GH and IGF-I as therapeutic agents for osteoporosis.
Agnusdei D; Gentilella R
J Endocrinol Invest; 2005; 28(8 Suppl):32-6. PubMed ID: 16323827
[TBL] [Abstract][Full Text] [Related]
11. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT; Christensen PM; Ejersted C; Langdahl BL
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
[TBL] [Abstract][Full Text] [Related]
12. Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review.
Martens MG
J Reprod Med; 2003 Jun; 48(6):425-34. PubMed ID: 12856513
[TBL] [Abstract][Full Text] [Related]
13. Clinical review 123: Anabolic therapy for osteoporosis.
Rosen CJ; Bilezikian JP
J Clin Endocrinol Metab; 2001 Mar; 86(3):957-64. PubMed ID: 11238469
[TBL] [Abstract][Full Text] [Related]
14. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
Epstein S
Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
[TBL] [Abstract][Full Text] [Related]
15. The prevention and treatment of osteoporosis: a review.
Cosman F
MedGenMed; 2005 May; 7(2):73. PubMed ID: 16369451
[TBL] [Abstract][Full Text] [Related]
16. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
[TBL] [Abstract][Full Text] [Related]
17. [Current research in therapy of postmenopausal osteoporosis (author's transl)].
Laroche C; Detilleux M; Sereni D
Sem Hop; 1979 Feb 18-25; 55(7-8):325-9. PubMed ID: 220722
[TBL] [Abstract][Full Text] [Related]
18. Past and future of anabolic agents.
Ringe JD
Ann Med Interne (Paris); 2000 Oct; 151(6):482-9. PubMed ID: 11104928
[No Abstract] [Full Text] [Related]
19. Management of osteoporosis due to ovarian failure.
Eastell R
Med Pediatr Oncol; 2003 Sep; 41(3):222-7. PubMed ID: 12868123
[TBL] [Abstract][Full Text] [Related]
20. [Parathyroid hormone for osteroporsis: why and who to treat?].
Ferrari S; Rizzoli R
Rev Med Suisse; 2005 Oct; 1(35):2272-4, 2276-7. PubMed ID: 16268450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
